Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo.
about
Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.Popdc1/Bves Functions in the Preservation of Cardiomyocyte Viability While Affecting Rac1 Activity and Bnip3 Expression.Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma.The effect of Bortezomib and Rapamycin on Telomerase Activity in Mantle Cell Lymphoma
P2860
Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Differential downregulation of ...... pathways in vitro and ex vivo.
@en
Differential downregulation of ...... pathways in vitro and ex vivo.
@nl
type
label
Differential downregulation of ...... pathways in vitro and ex vivo.
@en
Differential downregulation of ...... pathways in vitro and ex vivo.
@nl
prefLabel
Differential downregulation of ...... pathways in vitro and ex vivo.
@en
Differential downregulation of ...... pathways in vitro and ex vivo.
@nl
P2093
P2860
P356
P1476
Differential downregulation of ...... pathways in vitro and ex vivo.
@en
P2093
H Magen-Nativ
J Nordenberg
M Bakhanashvili
P2860
P2888
P304
P356
10.1038/BJC.2012.460
P407
P577
2012-11-01T00:00:00Z
P5875
P6179
1051470953